MEREO BIOPHARMA 3 LTD has a total of 25 patent applications. It decreased the IP activity by 91.0%. Its first patent ever was published in 2008. It filed its patents most often in United Kingdom, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MERRIMACK PHARMACEUTICALS INC, SHASHOUA VICTOR E and XU HANMEI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Chile | 1 | |
#9 | China | 1 | |
#10 | Hungary | 1 | |
#11 | Israel | 1 | |
#12 | Japan | 1 | |
#13 | Republic of Korea | 1 | |
#14 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Kneissel Michaela | 14 |
#2 | Riggs Matthew Manning | 11 |
#3 | Eudy Rena Joy | 11 |
#4 | Junker Uwe | 11 |
#5 | Hall Anthony Kent | 11 |
#6 | Taipaleenmaki Hanna | 3 |
#7 | Halleux Christine | 3 |
#8 | Prassler Josef | 3 |
#9 | Hesse Eric | 3 |
#10 | Hu Shou-Ih | 3 |
Publication | Filing date | Title |
---|---|---|
GB202005519D0 | Elastase inhibition | |
GB202005520D0 | Elastase inhibition | |
GB201905370D0 | Elastate inhibition | |
GB201810746D0 | Use of sclerostin antagonist | |
WO2018115879A1 | Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta | |
BR112019012731A2 | use of antisclerostin antibodies in the treatment of osteogenesis imperfecta | |
GB201720622D0 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary |